SCHEMBL1356833

SCHEMBL1356833

Cc1ccc(CB(O)O)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 3/20 0.46
CA2 P00918 1/20 0.46
LPL P06858 1/20 0.46
LIPG Q9Y5X9 1/20 0.46
ORAI1 Q96D31 1/20 0.46
ORAI2 Q96SN7 1/20 0.46
ORAI3 Q9BRQ5 1/20 0.46
TRPV6 Q9H1D0 1/20 0.46
CYP1A2 P05177 1/20 0.42
CYP2A6 P11509 1/20 0.42
TAAR1 Q96RJ0 1/20 0.42
ACHE P22303 2/20 0.42
TDP1 Q9NUW8 1/20 0.42
AGXT P21549 2/20 0.41
CA1 P00915 1/20 0.38
ALOX15 P16050 2/20 0.38
KDM4E B2RXH2 1/20 0.38
MEN1 O00255 1/20 0.38
ALDH1A1 P00352 1/20 0.38
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17576842 0.76 IDO1 (0.48) IDO1CA2LPLLIPGORAI1
SCHEMBL15740559 0.76 ESR1 (0.52) IDO1CA2TAAR1TDP1CA1
SCHEMBL910722 0.75 CA2 (0.60) IDO1CA2LPLLIPGORAI1
SCHEMBL1822656 0.74 F11 (0.56) CA2TAAR1CA1
SCHEMBL22010359 0.74 CYP3A4 (0.41) IDO1CYP1A2
SCHEMBL19692606 0.74 ALDH1A1 (0.50) TDP1ALOX15MEN1ALDH1A1MAPT
SCHEMBL28591555 0.74 TRPA1 (0.43) CA2LPLLIPGCA1ALDH1A1
SCHEMBL1358563 0.74 IDO1 (0.46) IDO1ORAI1ORAI2ORAI3TRPV6
SCHEMBL3568612 0.74 IDO1 (0.46) IDO1ORAI1ORAI2ORAI3TRPV6
SCHEMBL15106880 0.74 CA1 (0.46) IDO1CA2CYP2A6TAAR1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115959993-A Synthetic method of 2-aryl propionic acid compound 山东中医药大学 2023-04-14 CN claimed
CN-111057053-A Preparation method of zolpidem 复旦大学 2020-04-24 CN claimed
CN-119350352-A Spiral bisindole skeleton compound and catalytic construction method thereof 南方科技大学 2025-01-24 CN disclosed
CN-115160356-B Method for effectively preparing vinyl silane derivative through cascade three-component reaction 南阳师范学院 2024-01-26 CN disclosed
CN-115975231-A General preparation method of stretchable semiconductor film 江苏振宁半导体研究院有限公司 2023-04-18 CN disclosed
CN-114516870-B Triazolo hexa-nitrogen heterocyclic-3-amine compound and preparation method and application thereof 五邑大学 2023-04-11 CN disclosed
CN-112939716-B Preparation method of biphenyl compound 三峡大学 2023-01-06 CN disclosed
CN-114761413-A Carbapenem hydrolysis D-type beta-lactamase inhibitor and preparation method thereof 明知大学校产学协力团 2022-07-15 CN disclosed
CN-114685450-A 2-pyridone derivative, preparation method and medical application thereof 昆药集团股份有限公司 2022-07-01 CN disclosed
CN-110520416-B Polysubstituted pyridone derivative, preparation method and medical application thereof 北京越之康泰生物医药科技有限公司 2022-06-03 CN disclosed
CN-114560840-A 2, 7-diaryl xanthene spirofluorene diol derivative and preparation method thereof 常州南京大学高新技术研究院 2022-05-31 CN disclosed
US-20070135596-A1 Preparation of substituted bridged indenyl and related ligands EXXONMOBIL CHEMICAL PATENTS INC. 2007-06-14 US disclosed
US-20060160968-A1 Process for producing substituted metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-07-20 US disclosed
WO-2006065844-A2 PROCESS FOR PRODUCING SUBSTITUTED METALLOCENE COMPOUNDS FOR OLEFIN POLYMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2006-06-22 WO disclosed
EP-0736509-B1 Processes for preparing optically active alcohols and optically active amines SUMITOMO CHEMICAL CO (JP) 2001-11-14 EP disclosed
US-6025531-A REACTING A PROCHIRAL KETONE WITH A MIXTURE BORON-CONTAINING COMPOUNDS HAVING A BORANE REACTION PRODUCT FROM OPTICALLY ACTIVE BETA-AMINOALCOHOL AND A BORON HYDRIDE OR A METAL BOROHYDRIDE, AND AN OPTICALLY ACTIVE OXAZABOROLIDINE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2000-02-15 US disclosed
US-5801280-A Processes for preparing optically active alcohols and optically active amines SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1998-09-01 US disclosed
EP-0736509-A2 Processes for preparing optically active alcohols and optically active amines SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1996-10-09 EP disclosed
WO-1993014086-A1 SUBSTITUTED 1-ISOQUINOLONE DERIVATIVES AS ANGIOTENSIN II ANTAGONISTS SYNTEX (U.S.A.) INC. (US) 1993-07-22 WO disclosed
US-5212195-A Substituted indole antagonists derivatives which are angiotensin II SYNTEX (U.S.A.) INC. (US) 1993-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135596-A1 Preparation of substituted bridged indenyl and related ligands SP1, TTL, TTLL12 IDO1 794/4885CA2 312/4885LPL 2250/4885
US-20060160968-A1 Process for producing substituted metallocene compounds for olefin polymerization OSBP, OSBPL3, OSBP2 IDO1 2919/4885CA2 2434/4885LPL 1834/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.